113 related articles for article (PubMed ID: 17875793)
1. The dock and lock method: a novel platform technology for building multivalent, multifunctional structures of defined composition with retained bioactivity.
Chang CH; Rossi EA; Goldenberg DM
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5586s-5591s. PubMed ID: 17875793
[TBL] [Abstract][Full Text] [Related]
2. Multifunctional antibodies by the Dock-and-Lock method for improved cancer imaging and therapy by pretargeting.
Goldenberg DM; Rossi EA; Sharkey RM; McBride WJ; Chang CH
J Nucl Med; 2008 Jan; 49(1):158-63. PubMed ID: 18077530
[TBL] [Abstract][Full Text] [Related]
3. The dock-and-lock method combines recombinant engineering with site-specific covalent conjugation to generate multifunctional structures.
Rossi EA; Goldenberg DM; Chang CH
Bioconjug Chem; 2012 Mar; 23(3):309-23. PubMed ID: 22168393
[TBL] [Abstract][Full Text] [Related]
4. A new method to produce monoPEGylated dimeric cytokines shown with human interferon-α2b.
Chang CH; Rossi EA; Cardillo TM; Nordstrom DL; McBride WJ; Goldenberg DM
Bioconjug Chem; 2009 Oct; 20(10):1899-907. PubMed ID: 19736932
[TBL] [Abstract][Full Text] [Related]
5. Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting.
Rossi EA; Goldenberg DM; Cardillo TM; McBride WJ; Sharkey RM; Chang CH
Proc Natl Acad Sci U S A; 2006 May; 103(18):6841-6. PubMed ID: 16636283
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of AKAP specificity for PKA regulatory subunits.
Gold MG; Lygren B; Dokurno P; Hoshi N; McConnachie G; Taskén K; Carlson CR; Scott JD; Barford D
Mol Cell; 2006 Nov; 24(3):383-95. PubMed ID: 17081989
[TBL] [Abstract][Full Text] [Related]
7. Complex and defined biostructures with the dock-and-lock method.
Rossi EA; Goldenberg DM; Chang CH
Trends Pharmacol Sci; 2012 Sep; 33(9):474-81. PubMed ID: 22739259
[TBL] [Abstract][Full Text] [Related]
8. Engineering antibodies for stability and efficient folding.
Honegger A
Handb Exp Pharmacol; 2008; (181):47-68. PubMed ID: 18071941
[TBL] [Abstract][Full Text] [Related]
9. Solution scattering reveals large differences in the global structures of type II protein kinase A isoforms.
Vigil D; Blumenthal DK; Taylor SS; Trewhella J
J Mol Biol; 2006 Mar; 357(3):880-9. PubMed ID: 16460759
[TBL] [Abstract][Full Text] [Related]
10. Injectable shear-thinning hydrogels engineered with a self-assembling Dock-and-Lock mechanism.
Lu HD; Charati MB; Kim IL; Burdick JA
Biomaterials; 2012 Mar; 33(7):2145-53. PubMed ID: 22177842
[TBL] [Abstract][Full Text] [Related]
11. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
[TBL] [Abstract][Full Text] [Related]
12. Novel designs of multivalent anti-CD20 humanized antibodies as improved lymphoma therapeutics.
Rossi EA; Goldenberg DM; Cardillo TM; Stein R; Wang Y; Chang CH
Cancer Res; 2008 Oct; 68(20):8384-92. PubMed ID: 18922911
[TBL] [Abstract][Full Text] [Related]
13. PKA-I holoenzyme structure reveals a mechanism for cAMP-dependent activation.
Kim C; Cheng CY; Saldanha SA; Taylor SS
Cell; 2007 Sep; 130(6):1032-43. PubMed ID: 17889648
[TBL] [Abstract][Full Text] [Related]
14. Flexible protein-flexible ligand docking with disrupted velocity simulated annealing.
Huang Z; Wong CF; Wheeler RA
Proteins; 2008 Apr; 71(1):440-54. PubMed ID: 17957770
[TBL] [Abstract][Full Text] [Related]
15. Optimization of multivalent bispecific antibodies and immunocytokines with improved in vivo properties.
Rossi EA; Chang CH; Cardillo TM; Goldenberg DM
Bioconjug Chem; 2013 Jan; 24(1):63-71. PubMed ID: 23116517
[TBL] [Abstract][Full Text] [Related]
16. Structural analysis of ARC-type inhibitor (ARC-1034) binding to protein kinase A catalytic subunit and rational design of bisubstrate analogue inhibitors of basophilic protein kinases.
Lavogina D; Lust M; Viil I; König N; Raidaru G; Rogozina J; Enkvist E; Uri A; Bossemeyer D
J Med Chem; 2009 Jan; 52(2):308-21. PubMed ID: 19143565
[TBL] [Abstract][Full Text] [Related]
17. Protein-protein interaction regulates proteins' mechanical stability.
Cao Y; Yoo T; Zhuang S; Li H
J Mol Biol; 2008 May; 378(5):1132-41. PubMed ID: 18433770
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase A RII-like (R2D2) proteins exhibit differential localization and AKAP interaction.
Newell AE; Fiedler SE; Ruan JM; Pan J; Wang PJ; Deininger J; Corless CL; Carr DW
Cell Motil Cytoskeleton; 2008 Jul; 65(7):539-52. PubMed ID: 18421703
[TBL] [Abstract][Full Text] [Related]
19. A genetically encoded pore for the stochastic detection of a protein kinase.
Cheley S; Xie H; Bayley H
Chembiochem; 2006 Dec; 7(12):1923-7. PubMed ID: 17068836
[TBL] [Abstract][Full Text] [Related]
20. Antibody therapeutics, antibody engineering, and the merits of protein stability.
Demarest SJ; Glaser SM
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
